🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is to evaluate the safety and tolerability of SHR-1501 alone or i...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2022-11-23
Trial ID
NCT05410730
Treatments Being Tested
This study is an open, multicenter phase I/II clinical study. The entire st...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-07-24
Trial ID
NCT07073534
Treatments Being Tested
This is a multicenter, randomized, open-label phase III study to determine ...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-07-13
Trial ID
NCT07424287
This is a single-center, single-arm, phase Ib/II study, aimed at assessing ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-10-01
Trial ID
NCT06588179
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of SHR...
Status
Completed
Location
Sydney Southwest Private Hospital
Start Date
2020-02-14
Trial ID
NCT03995472
The purpose of this study is to evaluate the safety and tolerability of SHR...
Status
Completed
Location
Cancer hospital, Chinese academy of medical sciences
Start Date
2019-10-30
Trial ID
NCT04025957
Treatments Being Tested
This is a multicenter, randomized, Double-blind phase III study to determin...
Status
Not Yet Recruiting
Location
The First Medical Center of the Chinese People's Liberation Army General Hospital
Start Date
2026-07
Trial ID
NCT07726992
Treatments Being Tested